Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments

PALO ALTO, Calif., March 19 /PRNewswire-FirstCall/ -- Varian Medical
Systems (NYSE: VAR) has formed a council of leading cancer centers in North
America and Europe to further the development of clinical protocols using
its revolutionary RapidArc(TM) radiotherapy technology for fast and precise
cancer treatments. RapidArc makes it possible to deliver advanced
image-guided, intensity-modulated radiation therapy (IMRT) two to eight
times faster than is possible with conventional IMRT or helical
tomotherapy.

The RapidArc council members include researchers and scientists from
the VU University Medical Center in Amsterdam, Netherlands; Rigshospitalet
in Copenhagen, Denmark; CRLC Val d'Aurelle in Montpellier, France;
University Hospital in Zurich, Switzerland; BC Cancer Agency in Vancouver,
Canada; University of Maryland Marlene and Stewart Greenebaum Cancer Center
in Baltimore, USA; and University of Alabama at Birmingham, Alabama, USA.

PR Newswire